Wellington owns less than 5% of Genmab shares
In early July, the investment firm increased its stake in the Danish biotech firm to more than 5%, but Genmab now reports that this is no longer the case.
by marketwire, translated by daniel pedersen
US-based private investment firm Wellington Management Group LLP has decreased its share holding in Genmab to 4.9%, the Danish biotech firm reports in a Wednesday press release.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
Get full access for you and your coworkers
Start a free company trial todayRelated articles
Johnson & Johnson's Darzalex Q2 sales surpass projections
For subscribers
